{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:36:32Z","timestamp":1773830192812,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Arlene Witmer Memorial Fund for Bone Marrow Cancer Research"},{"name":"John and Denise Gilliland Fund for the Cancer Genetics Program"},{"name":"G. R. Sponaugle Employee Cancer Research Fund"},{"name":"Earl \"Bumps\" Clouser Memorial Lymphoma Research Endowment"},{"name":"Megan and Andrew Enders Stewardship"},{"name":"Richard E. and Stephanie A. Ziegler Charitable Foundation Endowment in Hematology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06657-8","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T07:10:56Z","timestamp":1760339456000},"page":"6451-6462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis"],"prefix":"10.1007","volume":"104","author":[{"given":"Natasha","family":"Venugopal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3967-7356","authenticated-orcid":false,"given":"Yoshitaka","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Cioccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Rakszawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natthapol","family":"Songdej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myles","family":"Nickolich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Ehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Sivik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Mierski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Silar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Vajdic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Shike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Mineishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Minagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"issue":"6","key":"6657_CR1","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, Gooley TA, Piantadosi S, Kaup M, Ambinder RF, Huff CA, Matsui W, Bolanos-Meade J, Borrello I, Powell JD, Harrington E, Warnock S, Flowers M, Brodsky RA, Sandmaier BM, Storb RF, Jones RJ, Fuchs EJ (2008) HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transpl 14(6):641\u2013650. https:\/\/doi.org\/10.1016\/j.bbmt.2008.03.005","journal-title":"Biol Blood Marrow Transpl"},{"issue":"25","key":"6657_CR2","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","volume":"388","author":"J Bolanos-Meade","year":"2023","unstructured":"Bolanos-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, Elmariah H, Rezvani AR, Gooptu M, Larkin KT, Shaffer BC, El Jurdi N, Loren AW, Solh M, Hall AC, Alousi AM, Jamy OH, Perales MA, Yao JM, Applegate K, Bhatt AS, Kean LS, Efebera YA, Reshef R, Clark W, DiFronzo NL, Leifer E, Horowitz MM, Jones RJ, Holtan SG, Investigators BC (2023) Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis. N Engl J Med 388(25):2338\u20132348. https:\/\/doi.org\/10.1056\/NEJMoa2215943","journal-title":"N Engl J Med"},{"issue":"2","key":"6657_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbmt.2019.09.030","volume":"26","author":"LP Wachsmuth","year":"2020","unstructured":"Wachsmuth LP, Patterson MT, Eckhaus MA, Venzon DJ, Kanakry CG (2020) Optimized timing of post-transplantation cyclophosphamide in MHC-haploidentical murine hematopoietic cell transplantation. Biol Blood Marrow Transpl 26(2):230\u2013241. https:\/\/doi.org\/10.1016\/j.bbmt.2019.09.030","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"6657_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00277-022-05077-2","volume":"102","author":"J Cioccio","year":"2023","unstructured":"Cioccio J, Rakszawski K, Zheng H, Nickolich M, Naik S, Wirk B, Rybka W, Ehmann C, Silar B, Vajdic C, Shah N, Tuanquin L, Greiner R, Brown V, Hohl R, Claxton D, Mineishi S, Minagawa K, Shike H (2023) Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis. Ann Hematol 102(3):613\u2013620. https:\/\/doi.org\/10.1007\/s00277-022-05077-2","journal-title":"Ann Hematol"},{"key":"6657_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2024.107530","volume":"143","author":"E Zulch","year":"2024","unstructured":"Zulch E, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, Zheng H, Naik S, Rybka W, Ehmann C, Sivik J, Mierski J, Silar B, Vajdic C, Greiner R, Brown V, Hohl R, Claxton D, Shike H, Paules CI, Mineishi S, Minagawa K (2024) Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leuk Res 143:107530. https:\/\/doi.org\/10.1016\/j.leukres.2024.107530","journal-title":"Leuk Res"},{"issue":"3","key":"6657_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41409-020-01065-0","volume":"56","author":"J Sugita","year":"2021","unstructured":"Sugita J, Kamimura T, Ishikawa T, Ota S, Eto T, Kuroha T, Miyazaki Y, Kumagai H, Matsuo K, Akashi K, Taniguchi S, Harada M, Teshima T (2021) Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation. Bone Marrow Transplant 56(3):596\u2013604. https:\/\/doi.org\/10.1038\/s41409-020-01065-0","journal-title":"Bone Marrow Transplant"},{"issue":"26","key":"6657_CR7","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1200\/jco.2017.72.8428","volume":"35","author":"A Bashey","year":"2017","unstructured":"Bashey A, Zhang MJ, McCurdy SR, St Martin A, Argall T, Anasetti C, Ciurea SO, Fasan O, Gaballa S, Hamadani M, Munshi P, Al Malki MM, Nakamura R, O\u2019Donnell PV, Perales MA, Raj K, Romee R, Rowley S, Rocha V, Salit RB, Solh M, Soiffer RJ, Fuchs EJ, Eapen M (2017) Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell-replete haploidentical donor transplantation using post-transplant cyclophosphamide. J Clin Oncol 35(26):3002\u20133009. https:\/\/doi.org\/10.1200\/jco.2017.72.8428","journal-title":"J Clin Oncol"},{"issue":"1","key":"6657_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41409-023-02131-z","volume":"59","author":"C Ustun","year":"2024","unstructured":"Ustun C, Chen M, Kim S, Auletta JJ, Batista MV, Battiwalla M, Cerny J, Gowda L, Hill JA, Liu H, Munshi PN, Nathan S, Seftel MD, Wingard JR, Chemaly RF, Dandoy CE, Perales MA, Riches M, Papanicolaou GA (2024) Post-transplantation cyclophosphamide is associated with increased bacterial infections. Bone Marrow Transplant 59(1):76\u201384. https:\/\/doi.org\/10.1038\/s41409-023-02131-z","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"6657_CR9","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1182\/bloodadvances.2024014879","volume":"9","author":"MA Hyder","year":"2025","unstructured":"Hyder MA, Dimitrova D, Sabina R, DeVries A, McCune JS, McAdams MJ, Flomerfelt FA, McKeown C, Sadler JL, Chai A, Hughes TE, Napier S, Stokes A, Sponaugle J, Rechache K, Parta M, Cuellar-Rodriguez J, Figg WD, Choo-Wosoba H, Steinberg SM, Kanakry JA, Kanakry CG (2025) Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation. Blood Adv 9(10):2553\u20132569. https:\/\/doi.org\/10.1182\/bloodadvances.2024014879","journal-title":"Blood Adv"},{"issue":"10","key":"6657_CR10","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1038\/s41409-021-01328-4","volume":"56","author":"A Esquirol","year":"2021","unstructured":"Esquirol A, Pascual MJ, Kwon M, Perez A, Parody R, Ferra C, Garcia Cadenas I, Herruzo B, Dorado N, Hernani R, Sanchez-Ortega I, Torrent A, Sierra J, Martino R, Spanish Group for Hematopoietic Stem cell T (2021) Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. Bone Marrow Transpl 56(10):2432\u20132444. https:\/\/doi.org\/10.1038\/s41409-021-01328-4","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"6657_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.bbmt.2014.04.003","volume":"20","author":"X Tang","year":"2014","unstructured":"Tang X, Alatrash G, Ning J, Jakher H, Stafford P, Zope M, Shpall EJ, Jones RB, Champlin RE, Thall PF, Andersson BS (2014) Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time. Biol Blood Marrow Transplant 20(8):1139\u20131144. https:\/\/doi.org\/10.1016\/j.bbmt.2014.04.003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"6657_CR12","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.exphem.2015.07.006","volume":"43","author":"H Nakamae","year":"2015","unstructured":"Nakamae H, Koh H, Katayama T, Nishimoto M, Hayashi Y, Nakashima Y, Nakane T, Nakamae M, Hirose A, Hino M (2015) HLA haploidentical peripheral blood stem cell transplantation using reduced dose of posttransplantation cyclophosphamide for poor-prognosis or refractory leukemia and myelodysplastic syndrome. Exp Hematol 43(11):921\u2013929e921. https:\/\/doi.org\/10.1016\/j.exphem.2015.07.006","journal-title":"Exp Hematol"},{"issue":"10","key":"6657_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26296","volume":"96","author":"O Jamy","year":"2021","unstructured":"Jamy O, Innis-Shelton R, Bal S, Paluri R, Salzman D, Di Stasi A, Costa L, Meredith R, Lamb L, Minagawa K, Mineishi S, Saad A (2021) Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation. Am J Hematol 96(10):E396\u2013E398. https:\/\/doi.org\/10.1002\/ajh.26296","journal-title":"Am J Hematol"},{"key":"6657_CR14","doi-asserted-by":"crossref","unstructured":"Thakar MS et al (2012) Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia. Pediatr Hematol Oncol 29(6): 568-578.","DOI":"10.3109\/08880018.2012.708708"},{"issue":"Supplement 1","key":"6657_CR15","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.1182\/blood-2018-99-112436","volume":"132","author":"S Morishige","year":"2018","unstructured":"Morishige S et al (2018) Reduced dose of post-transplant cyclophosphamide for HLA haploidentical peripheral blood stem cell transplantation. Blood 132(Supplement 1):5698\u20135698","journal-title":"Blood"},{"issue":"6","key":"6657_CR16","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00277-019-03673-3","volume":"98","author":"Y Soltermann","year":"2019","unstructured":"Soltermann Y et al (2019) Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study. Ann Hematol 98(6):1485\u20131493","journal-title":"Ann Hematol"},{"issue":"11","key":"6657_CR17","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.bbmt.2019.07.010","volume":"25","author":"M Ayas","year":"2019","unstructured":"Ayas M (2019) Successful outcome in patients with Fanconi anemia undergoing T cell-replete mismatched related donor hematopoietic cell transplantation using reduced-dose cyclophosphamide post-transplantation. Biol Blood Marrow Transplant 25(11):2217\u20132221","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"6657_CR18","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.bbmt.2020.08.019","volume":"26","author":"R Uppuluri","year":"2020","unstructured":"Uppuluri R et al (2020) Haploidentical stem cell transplantation with Post-Transplant cyclophosphamide in Fanconi anemia: improving outcomes with improved supportive care in India. Biol Blood Marrow Transpl 26(12):2292\u20132298","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"6657_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41598-020-80531-7","volume":"11","author":"Y Zu","year":"2021","unstructured":"Zu Y et al (2021) Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA. Sci Rep 11(1):253","journal-title":"Sci Rep"},{"issue":"7","key":"6657_CR20","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/s41409-021-01282-1","volume":"56","author":"A Al-Seraihy","year":"2021","unstructured":"Al-Seraihy A et al (2021) T-cell replete haploidentical transplantation with reduced post-transplant cyclophosphamide in six children with infantile osteopetrosis. Bone Marrow Transplant 56(7):1757\u20131760","journal-title":"Bone Marrow Transplant"},{"issue":"Supplement 1","key":"6657_CR21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1182\/blood-2023-189430","volume":"142","author":"H Zhang","year":"2023","unstructured":"Zhang H et al (2023) Phase I\/II study of reduced dosing of Post-Transplantation cyclophosphamide (PTCy) after HLA-Identical peripheral blood hematopoietic stem cell transplantation. Blood 142(Supplement 1):650\u2013650","journal-title":"Blood"},{"issue":"11","key":"6657_CR22","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1038\/s41409-024-02405-0","volume":"59","author":"S Fuji","year":"2024","unstructured":"Fuji S et al (2024) Lower-dose post-transplant cyclophosphamide in haploidentical hematopoietic cell transplantation. Bone Marrow Transplant 59(11):1628\u20131630","journal-title":"Bone Marrow Transplant"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06657-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06657-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06657-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:15:17Z","timestamp":1767485717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06657-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":22,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6657"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06657-8","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of Penn State Cancer Institute (STUDY00020839). This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was waived by the institutional review board as part of the exemption determination for this retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Patient consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}